Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Neuroscience Letters

• Publication date

  1995-02-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0304-3940(95)11324-PPMID 7617307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The involvement of the cerebral cortex in human immunodeficiency virus encephalopathy: a morphological and immunohistochemical study

  2004cited by this paper
• Increased Concentrations of the Neurotoxin 3‐Hydroxykynurenine in the Frontal Cortex of HIV‐1‐Positive Patients

  1995cited by this paper
• Cerebrospinal fluid human immunodeficiency virus type 1 (HIV‐1) p24 antigen levels in HIV‐1–related dementia

  1994cited by this paper
• Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice

  1994cited by this paper
• Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice.

  1994cited by this paper
• Mechanism of Delayed Increases in Kynurenine Pathway Metabolism in Damaged Brain Regions Following Transient Cerebral Ischemia

  1993cited by this paper
• Neuronal number and volume alterations in the neocortex of HIV infected individuals.

  1993cited by this paper
• Oxidation of 3-hydroxykynurenine catalyzed by methemoglobin with hydrogen peroxide.

  1992cited by this paper
• Cytokine expression in the brain during the acquired immunodeficiency syndrome

  1992cited by this paper
• Cortical dendritic pathology in human immunodeficiency virus encephalitis.

  1992cited by this paper
• Neocortical damage during HIV infection

  1991cited by this paper
• Neuronal loss in the frontal cortex in HIV infection.

  1991cited by this paper
• Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques.

  1991cited by this paper
• The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine

  1990cited by this paper
• Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome.

  1989cited by this paper
• Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line.

  1989cited by this paper
• Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome

  1989cited by this paper
• Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex.

  1989cited by this paper
• The AIDS dementia complex.

  1988cited by this paper
• Systemic Lipopolysaccharide and Pokeweed Mitogen Increase Quinolinic Acid Content of Mouse Cerebral Cortex

  1988cited by this paper
• Induction of indoleamine dioxygenase by interferon in mice: a study with different recombinant interferons and various cytokines.

  1988cited by this paper
• The AIDS dementia complex: I. Clinical features

  1986cited by this paper
• The AIDS dementia complex: II. Neuropathology

  1986cited by this paper
• Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.

  1986cited by this paper
• Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme.

  1985cited by this paper
• Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain.

  1983cited by this paper
• Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS.

  1981cited by this paper

• Expression and Function of Long Non-coding RNA in Endemic Cretinism

  2024cites this paper
• Through the Looking-Glass: Psychoneuroimmunology and the Microbiome-Gut-Brain Axis in the Modern Antiretroviral Therapy Era

  2022cites this paper
• Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?

  2021cites this paper
• Covid-19 interface with drug misuse and substance use disorders

  2021cites this paper
• Gut Microbiome Alterations During HIV/SIV Infection: Implications for HIV Cure

  2019cites this paper
• A Three-Ring Circus: Metabolism of the Three Proteogenic Aromatic Amino Acids and Their Role in the Health of Plants and Animals

  2018cites this paper
• Ferulic acid suppresses expression of tryptophan metabolic key enzyme indoleamine 2, 3-dioxygenase via NFκB and p38 MAPK in lipopolysaccharide-stimulated microglial cells

  2017cites this paper
• Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases

  2017cites this paper
• Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.

  2017cites this paper
• Nitrobenzofurazan derivatives of N'-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1.

  2016cites this paper
• Role of indoleamine 2,3-dioxygenase in health and disease.

  2015cites this paper
• HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets

  2015cites this paper
• The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.

  2014cites this paper
• Anti-tat Hutat 2 : Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages

  2014cites this paper
• Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages

  2014cites this paper
• Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease

  2014cites this paper
• Quinolinate and related excitotoxins: mechanisms of neurotoxicity and disease relevance

  2014cites this paper
• Immuno-modulatory Role of Indoleamine 2, 3-Dioxygenase in Allogeneic Islet and Skin Transplantation

  2013cites this paper
• virus-infected macrophages in animal model of HIV-1 encephalitis Inhibition of Indoleamine 2,3-dioxygenase (IDO) enhances elimination of

  2013cites this paper
• Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.

  2013cites this paper
• Structure and mechanism of kynurenine 3-monooxygenase, a candidate huntington’s disease drug target

  2013cites this paper
• Investigating innate and adaptive immune responses against sexually transmitted viral infections

  2013cites this paper
• Oxidative Stress and the HIV-Infected Brain Proteome

  2013cites this paper
• The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease

  2013cites this paper
• 3-Hydroxykynurenine: an intriguing molecule exerting dual actions in the central nervous system.

  2013cites this paper
• The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders

  2012cites this paper
• Differential regulation of neurotoxin in HIV clades: role of cocaine and methamphetamine.

  2012cites this paper
• Kynurenines in the CNS: recent advances and new questions

  2012cites this paper
• Human immunodeficiency virus type 1 clade B and C gp120 differentially induce neurotoxin arachidonic acid in human astrocytes: implications for neuroAIDS

  2011cites this paper
• HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner

  2011cites this paper
• Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.

  2011cites this paper
• Dual lentivirus infection potentiates neuroinflammation and neurodegeneration: viral copassage enhances neurovirulence

  2009cites this paper
• Differential Regulation of Indoleamine-2,3-Dioxygenase (IDO) by HIV Type 1 Clade B and C Tat Protein

  2009cites this paper
• The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.

  2009cites this paper
• Cytoplasmic calcium mediates oxidative damage in an excitotoxic /energetic deficit synergic model in rats

  2008cites this paper
• Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid.

  2007cites this paper
• IDO expression in the brain: a double-edged sword

  2007cites this paper
• A study of tryptophan metabolism via serotonin in ventricular cerebrospinal fluid in HIV-1 infection using a neuroendoscopic technique.

  2007cites this paper
• Lentivirus envelope protein exerts differential neuropathogenic effects depending on the site of expression and target cell.

  2006cites this paper
• Inhibition of indoleamine 2,3 dioxygenase activity by H2O2.

  2006cites this paper
• An investigation of the activities of 3-hydroxykynureninase and kynurenine aminotransferase in the brain in Huntington's disease

  2005cites this paper
• Inhibition of Indoleamine 2 , 3-dioxygenase ( IDO ) enhances elimination of virus-infected macrophages in animal model of HIV-1 encephalitis

  2005cites this paper
• Indoleamine 2,3-Dioxygenase Mediates Cell Type-Specific Anti-Measles Virus Activity of Gamma Interferon

  2005cites this paper
• Indolamine 2,3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation

  2005cites this paper
• Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis.

  2005cites this paper
• Theoretical study on 3-hydroxykynurenine transaminase by homology modeling and molecular dynamics

  2005cites this paper
• Neuronal localization of indoleamine 2,3-dioxygenase in mice.

  2005cites this paper
• Expression of indoleamine 2,3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

  2005cites this paper
• Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment.

  2004cites this paper
• Brain virus burden and indoleamine‐2,3‐dioxygenase expression during lentiviral infection of rhesus monkey are concomitantly lowered by 6‐chloro‐2′,3′‐dideoxyguanosine

  2004cites this paper
• Asp274 and His346 Are Essential for Heme Binding and Catalytic Function of Human Indoleamine 2,3-Dioxygenase*

  2003cites this paper
• Tryptophan Metabolites and Brain Disorders

  2003cites this paper
• Tryptophan depletion and HIV infection: a metabolic link to pathogenesis.

  2003cites this paper
• Tryptophan and the immune response

  2003cites this paper
• Production of truncated enzymically active human indoleamine 2,3-dioxygenase using site-directed mutagenesis

  2002cites this paper
• Regulation of Indoleamine 2,3-Dioxygenase Expression in Simian Immunodeficiency Virus-Infected Monkey Brains

  2002cites this paper
• Endogenous kynurenines as targets for drug discovery and development

  2002cites this paper
• Seeing red but not blue: model studies on the ageing human lens

  2002cites this paper
• 3-Hydroxykynurenine Transaminase Identity with Alanine Glyoxylate Transaminase

  2002cites this paper
• Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.

  2001cites this paper
• Endogenous neurotoxins from tryptophan.

  2001cites this paper
• The role of kynurenines in the production of neuronal death, and the neuroprotective effect of purines

  2001cites this paper
• Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway.

  2000cites this paper
• Induction of Indolamine 2,3-Dioxygenase in Primary Human Macrophages by Human Immunodeficiency Virus Type 1 Is Strain Dependent

  2000cites this paper
• Expression and purification of recombinant human indoleamine 2, 3-dioxygenase.

  2000cites this paper
• Kynurenic acid metabolism in the brain of HIV-1 infected patients

  2000influential citation
• Preferential loss of large neocortical neurons during HIV infection: a study of the size distribution of neocortical neurons in the human brain.

  1999cites this paper
• Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS.

  1999cites this paper
• Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

  1999cites this paper
• Evidence for increased de novo synthesis of NAD in immune-activated RAW264.7 macrophages: a self-protective mechanism?

  1999cites this paper
• Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients.

  1998cites this paper
• 5-Hydroxytryptamine deficits in the caudate nucleus in AIDS.

  1996cites this paper